×
For best experience we recommend to activate Javascript in your browser.
QTRTD1 antibody (C-Term)
QTRTD1
Reactivity: Human
WB, FACS, IF, IHC, ELISA
Host: Rabbit
Polyclonal
unconjugated
Product Details anti-QTRTD1 Antibody
(hide)
Target
See all QTRTD1 Antibodies
QTRTD1
(Queuine tRNA-Ribosyltransferase Domain Containing 1 (QTRTD1))
Binding Specificity
All epitopes for QTRTD1 antibodies
AA 328-359, C-Term
Reactivity
All reactivities for QTRTD1 antibodies
Human
Host
All hosts for QTRTD1 antibodies
Rabbit
Clonality
All clonalities for QTRTD1 antibodies
Polyclonal
Conjugate
All conjugates for QTRTD1 antibodies
This QTRTD1 antibody is un-conjugated
Application
All applications for QTRTD1 antibodies
Western Blotting (WB), Flow Cytometry (FACS), Immunofluorescence (IF), Immunohistochemistry (IHC), ELISA
Cross-Reactivity
Human
Cross-Reactivity (Details)
Calculated cross reactivity: Hu
Characteristics
QTRTD1, CT (QTRTD1, Queuine tRNA-ribosyltransferase subunit QTRTD1, Queuine tRNA-ribosyltransferase domain-containing protein 1)
Purification
Purified by Protein A affinity chromatography.
Immunogen
QTRTD1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 328-359 amino acids from the C-terminal region of human QTRTD1.
Isotype
IgG
Top Product
Discover our top product QTRTD1 Primary Antibody
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working conditions should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
-20 °C
Storage Comment
-20°C
Target Details for QTRTD1
(hide)
Target
QTRTD1
(Queuine tRNA-Ribosyltransferase Domain Containing 1 (QTRTD1))
Alternative Name
QTRTD1 (QTRTD1 Products )
NCBI Accession
NP_078914
UniProt
Q9H974
Pathways
Ribonucleoside Biosynthetic Process
Recently viewed
(hide)
Chat with us , powered by LiveChat